NPCE - Neuropace Inc
Neuropace Inc Logo

NPCE - Neuropace Inc

https://www.neuropace.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.

52W High
$18.98
52W Low
$5.45
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.90
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-16.94
EV/Revenue (<3 favorable)
3.74
P/S (TTM) (<3 favorable)
3.63
P/B (<3 favorable)
16.56
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
2.71%
Institutions (25–75% balanced)
82.15%
Shares Outstanding
33,081,500
Float
22,521,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
88,570,000
Gross Profit (TTM)
67,082,000
EPS (TTM)
-0.82
Profit Margin (>10% good)
-0.29%
Operating Margin (TTM) (higher better)
-0.29%
ROE (TTM) (>15% strong)
-1.77%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.22
Momentum
Bearish momentum
Value
0.2561
Previous
0.2440
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025